Rocket Pharmaceuticals, Inc. Warrant
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; l… Read more
Market Cap & Net Worth: Rocket Pharmaceuticals, Inc. Warrant (RCKTW)
Rocket Pharmaceuticals, Inc. Warrant (NASDAQ:RCKTW) has a market capitalization of $186.68 ($186.68) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #49725 globally and #15191 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rocket Pharmaceuticals, Inc. Warrant's stock price $0.02 by its total outstanding shares 9381 (9.38K).
Rocket Pharmaceuticals, Inc. Warrant Market Cap History: 2023 to 2026
Rocket Pharmaceuticals, Inc. Warrant's market capitalization history from 2023 to 2026. Data shows change from $4.60K to $186.68 (-58.89% CAGR).
Rocket Pharmaceuticals, Inc. Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rocket Pharmaceuticals, Inc. Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of RCKTW by Market Capitalization
Companies near Rocket Pharmaceuticals, Inc. Warrant in the global market cap rankings as of March 19, 2026.
Key companies related to Rocket Pharmaceuticals, Inc. Warrant by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Rocket Pharmaceuticals, Inc. Warrant Historical Marketcap From 2023 to 2026
Between 2023 and today, Rocket Pharmaceuticals, Inc. Warrant's market cap moved from $4.60K to $ 186.68, with a yearly change of -58.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $186.68 | -18.11% |
| 2025 | $227.96 | -29.15% |
| 2024 | $321.77 | -93.00% |
| 2023 | $4.60K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Rocket Pharmaceuticals, Inc. Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $186.68 USD |
| MoneyControl | $186.68 USD |
| MarketWatch | $186.68 USD |
| marketcap.company | $186.68 USD |
| Reuters | $186.68 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.